J&J/Merck Mevacor Tests Include Subjects With Slightly Elevated Cholesterol
This article was originally published in The Tan Sheet
Executive Summary
J&J/Merck is evaluating Merck's Mevacor (lovastatin) as an OTC candidate by testing the prescription cholesterol reducer in subjects with slightly elevated cholesterol levels. The company has not yet filed an application to switch Mevacor to OTC status.